UBS Maintains a 'Buy' on Amdocs Ltd (DOX); Continuing to Deliver Solid Results

July 28, 2011 10:26 AM EDT Send to a Friend
UBS maintains a 'Buy' on Amdocs Ltd. (NYSE: DOX) price target raised from $33 to $35.

UBS analyst says, "Managed ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login